Literature DB >> 14625275

Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase.

Dennis Fiegen1, Lars-Christian Haeusler, Lars Blumenstein, Ulrike Herbrand, Radovan Dvorsky, Ingrid R Vetter, Mohammad R Ahmadian.   

Abstract

Rac1b was recently identified in malignant colorectal tumors as an alternative splice variant of Rac1 containing a 19-amino acid insertion next to the switch II region. The structures of Rac1b in the GDP- and the GppNHp-bound forms, determined at a resolution of 1.75 A, reveal that the insertion induces an open switch I conformation and a highly mobile switch II. As a consequence, Rac1b has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins. Interestingly, Rac1b is able to bind the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction. The presented study provides insights into the structural and biochemical mechanism of a self-activating GTPase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625275     DOI: 10.1074/jbc.M310281200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

Review 2.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

Authors:  Paola Nisticò; Mina J Bissell; Derek C Radisky
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

3.  SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling.

Authors:  Feng Wang; Xing Fu; Peng Chen; Ping Wu; Xiaojuan Fan; Na Li; Hong Zhu; Ting-Ting Jia; Hongbin Ji; Zefeng Wang; Catherine C L Wong; Ronggui Hu; Jingyi Hui
Journal:  Cell Res       Date:  2017-01-13       Impact factor: 25.617

4.  Evolution of the Rho family of ras-like GTPases in eukaryotes.

Authors:  Anthony Boureux; Emmanuel Vignal; Sandrine Faure; Philippe Fort
Journal:  Mol Biol Evol       Date:  2006-10-11       Impact factor: 16.240

Review 5.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

6.  Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b.

Authors:  Anjaruwee S Nimnual; Laura J Taylor; Marian Nyako; Hao-Hsuan Jeng; Dafna Bar-Sagi
Journal:  Small GTPases       Date:  2010-09

7.  Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).

Authors:  Mamta Jaiswal; Lothar Gremer; Radovan Dvorsky; Lars Christian Haeusler; Ion C Cirstea; Katharina Uhlenbrock; Mohammad Reza Ahmadian
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

Review 8.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

Review 9.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

10.  Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.

Authors:  Takao Kamai; Hiromichi Shirataki; Kimihiro Nakanishi; Nobutaka Furuya; Tsunehito Kambara; Hideyuki Abe; Tetsunari Oyama; Ken-Ichiro Yoshida
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.